The pharmaceutical market is experiencing a surge in popularity for Ozempic, a drug used to treat type 2 diabetes and promote weight loss. This is due to its effectiveness in managing blood sugar levels and encouraging weight loss. As consumers prioritize their health and wellness, the increased use of Ozempic and other GLP-1 drugs reflects this trend.
This report explores the effects of the widespread use of GLP-1 drugs on various sectors of the US retail market, including grocery and apparel. Companies such as Hershey, Lululemon Athletica, Mondelez International, NIKE, PepsiCo and Walmart are mentioned in this report, showcasing the potential impact on these businesses.
Subscribers can access this subscriber-only report by logging in and gaining valuable insights into this topic. If you are not a subscriber, you can learn more about subscriptions and access to relevant research.